Clinical Trial Update: Tricaprilin In Age-Associated Memory Impairment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for tricaprilin in age-associated memory impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-associated Memory Impairment

Drugs mentioned

• Tricaprilin (tricaprilin)

Snippet

Sponsor: Cerecin | Conditions: Age-Associated Memory Impairment | Phase 2 | Status: COMPLETED